Ind-Swift Laboratories Limited (NSE:INDSWFTLAB)
India · Delayed Price · Currency is INR 331.20
-14.15 (-4.10%)
Oct 23, 2026, 2:35 PM IST
Ind-Swift Laboratories Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 22, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 28,802 | 11,397 | 4,961 | 5,918 | 3,262 | 3,938 | |
Market Cap Growth | 236.49% | 129.72% | -16.17% | 81.43% | -17.18% | -7.37% |
Enterprise Value | 24,589 | 7,424 | 740 | 13,802 | 12,284 | 13,491 |
Last Close Price | 345.35 | 131.43 | 83.96 | 100.15 | 55.20 | 66.65 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 22, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 51.16 | 26.43 | 1.98 | 1.10 | 6.85 | - |
PS Ratio | 4.45 | 1.76 | 0.86 | 0.35 | 0.27 | 0.37 |
PB Ratio | 2.17 | 0.82 | 0.42 | 0.73 | 0.48 | 0.66 |
P/TBV Ratio | 2.21 | 0.84 | 0.43 | 0.74 | 0.48 | 0.66 |
P/FCF Ratio | - | - | - | - | 1.79 | 2.99 |
P/OCF Ratio | - | - | - | - | 1.68 | 2.62 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 22, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 3.83 | 1.14 | 0.13 | 0.81 | 1.01 | 1.28 |
EV/EBITDA Ratio | 36.54 | 16.68 | - | 4.51 | 5.14 | 6.04 |
EV/EBIT Ratio | 68.10 | 45.34 | - | 6.11 | 6.77 | 14.60 |
EV/FCF Ratio | - | - | - | - | 6.76 | 10.23 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 22, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.02 | 0.02 | 0.04 | 0.27 | 1.26 | 1.59 |
Debt / EBITDA Ratio | 0.29 | 0.46 | - | 0.71 | 3.61 | 4.26 |
Debt / FCF Ratio | - | - | - | - | 4.74 | 7.23 |
Net Debt / Equity Ratio | -0.30 | -0.30 | -0.36 | -0.34 | 1.24 | 1.55 |
Net Debt / EBITDA Ratio | -5.97 | -9.46 | 61.66 | -0.90 | 3.53 | 4.17 |
Net Debt / FCF Ratio | - | 2.70 | 4.55 | 1.07 | 4.64 | 7.07 |
Asset Turnover | - | 0.42 | 0.40 | 1.04 | 0.67 | 0.58 |
Inventory Turnover | - | 2.20 | 3.05 | 3.39 | 1.51 | 1.34 |
Quick Ratio | - | 2.55 | 2.88 | 1.94 | 1.48 | 1.54 |
Current Ratio | - | 3.80 | 3.92 | 2.22 | 3.14 | 3.22 |
Return on Equity (ROE) | - | 3.37% | 25.24% | 72.12% | 7.42% | -0.36% |
Return on Assets (ROA) | - | 0.66% | -1.35% | 8.60% | 6.26% | 3.19% |
Return on Invested Capital (ROIC) | 3.16% | 1.62% | -4.74% | 19.76% | 6.55% | -1.01% |
Return on Capital Employed (ROCE) | - | 1.20% | -2.60% | 22.00% | 12.50% | 6.30% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 22, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 1.95% | 3.78% | 50.49% | 91.04% | 14.59% | -0.55% |
FCF Yield | -5.19% | -13.68% | -18.77% | -43.94% | 55.75% | 33.48% |
Buyback Yield / Dilution | -21.16% | -20.40% | -20.41% | - | - | - |